Evidence map›Paper›PMID 26951636›Full record

ArticleNephron extra

A Higher Cardiothoracic Ratio Is Associated with 2-Year Mortality after Hemodialysis Initiation.

Kiyonori Ito, Susumu Ookawara, Yuichiro Ueda, Haruhisa Miyazawa, Hodaka Yamada, Sawako Goto, Hiroki Ishii, Mitsutoshi Shindo, Taisuke Kitano, Keiji Hirai and 9 more

Abstract read
In one paragraph

Article in Nephron extra. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Kiyonori ItoDivisions of Nephrology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Susumu OokawaraDivisions of Nephrology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Yuichiro UedaDivisions of Nephrology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Haruhisa MiyazawaDivisions of Nephrology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Hodaka YamadaEndocrinology and Metabolism, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Sawako GotoDivision of Clinical Nephrology and Rheumatology, Niigata University Medical and Dental Hospital, Japan.
Hiroki IshiiDivisions of Nephrology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Mitsutoshi ShindoDivisions of Nephrology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Taisuke KitanoDivisions of Nephrology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Keiji HiraiDivisions of Nephrology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Masashi YoshidaEndocrinology and Metabolism, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Yoshio KakuDivisions of Nephrology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Taro HoshinoDivisions of Nephrology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Aoi NabataDivisions of Nephrology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Honami MoriDivisions of Nephrology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Izumi YoshidaUsui Hospital, Annaka, Japan.
Masafumi KakeiEndocrinology and Metabolism, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Yoshiyuki MorishitaDivisions of Nephrology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Kaoru TabeiDivisions of Nephrology, Saitama Medical Center, Jichi Medical University, Saitama, Japan; Minami-Uonuma City Hospital, Niigata, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledA high cardiothoracic ratio (CTR) is indicative of a cardiac disorder. However, few reports have revealed an association between the CTR and mortality in patients starting hemodialysis (HD).

methodsPatients with HD initiation (n = 387; mean age, 66.7 ± 12.7 years) were divided into the following three groups according to their CTR at HD initiation: CTR <50%, 50% ≤ CTR < 55%, and CTR ≥55%. Kaplan-Meier analysis was performed to compare 2-year all-cause mortality among these groups. Furthermore, we investigated the factors affecting their 2-year mortality using a Cox proportional hazard regression analysis.

resultsSixty-five patients (17%) died within 2 years after HD initiation. Kaplan-Meier analysis showed that patients with CTR ≥55% had a higher mortality rate than those in the other groups. Cox proportional hazard regression analysis was performed using parameters with p values <0.1 among these three groups [sex, age, presence or absence of ischemic heart disease, hemoglobin levels, serum albumin levels, CTR, body mass index (BMI)] and confounding factors [presence or absence of diabetes mellitus, and estimated glomerular filtration rate (eGFR)]. Age, eGFR, BMI, and CTR ≥55% at HD initiation were identified as factors influencing 2-year mortality.

conclusionCTR >55% is one of the most important independent factors to affect 2-year all-cause mortality. Thus, confirming the cardiac condition of patients at HD initiation with a CTR >55% may improve their survival.

Indexed as

Cardiothoracic ratioDiabetes mellitusHemodialysisIschemic heart diseaseMortality

Identifiers

PMID26951636
PMCPMC4777940

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.